News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Omid Hamid: CTLA-4 Conditionally Active shows tolerability with full dose Nivolumab
Omid Hamid/globaloncologyacademy.org
Feb 28, 2025, 13:46

Omid Hamid: CTLA-4 Conditionally Active shows tolerability with full dose Nivolumab

Omid Hamid, Chief of Clinical Translational Research and Immunotherpeutics at the Angeles Clinic and Research Insititute, shared a post on X:

“AACR IO in Los Angeles BioAtl CTLA-4 Conditionally Active shows tolerability with full dose Nivolumab Bristol Myers Squibb stressing the need to continue to develop CTLA4 – great meeting led by Toni Ribas.”

Ankit Mangla, Sarcoma and Cutaneous Oncology Specialist at the Seidman Cancer Center, shared this post, adding:

“Congratulations to team Bioatl. We need next generation anti-CTLA4 to ensure better delivery and higher efficacy.”

Omid Hamid: CTLA-4 Conditionally Active shows tolerability with full dose Nivolumab

More posts featuring Omid Hamid and Ankit Mangla.

Ankit Mangla cancer Omid Hamid OncoDaily Oncology
Special Coverage
Blog
Apr 1, 2025, 17:01
The Power Over Cancer Gathering at Springhill Church - UF Health Cancer Center
Blog
Apr 1, 2025, 16:40
Estelamari Rodriguez: Speaking at the Latino Medical Student Association regional conference
Blog
Apr 1, 2025, 16:32
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers
Blog
Apr 1, 2025, 16:21
Azra Raza featured in SPCC's fifth episode of the "Behind Every Drug There’s a Story" series
Blog
Apr 1, 2025, 16:18
The EBMT 2025 Election Results
Career
Apr 1, 2025, 16:02
Jay Bhattacharya begins his tenure as the 18th NIH Director - National Institutes of Health
Positive
Apr 1, 2025, 15:45
Mark Lanasa: Positive CHMP opinion for BeOne Medicines' first-line immunotherapy in ES-SCLC
Blog
Apr 1, 2025, 15:09
Hagop Kantarjian: Success, optimism, and challenges on the therapeutic horizon of acute myeloid leukemia
Blog
Apr 1, 2025, 15:04
Call for Papers: AI in Immune-Related Adverse Events (irAEs) - AI in Precision Oncology
Career
Apr 1, 2025, 14:57
Sharon Burk completes PhD with groundbreaking research - Sbarro Health Research Organization
Blog
Apr 1, 2025, 14:35
Douglas Flora: The messy truth behind healthcare's coming AI adoption
Blog
Apr 1, 2025, 14:31
Zainab Shinkafi-Bagudu: Processed meats and fried snacks may increase the risk of colorectal cancer